All Stories

  1. Cerebral venous thrombosis in non-bacterial infections: a systematic review
  2. Viral, Clinical, and Epidemiological Characteristics of Oropouche Fever in Southeastern Brazil
  3. Sustained Oropouche virus transmission in Rio de Janeiro’s Atlantic forest: genomic evidence over a two-year period
  4. Natural, vaccine-induced immunity and the probability of experiencing SARS-CoV-2 infection in a household cohort in Rio de Janeiro
  5. Adverse fetal and perinatal outcomes associated with Zika virus infection during pregnancy: an individual participant data meta-analysis
  6. Transitions through the HIV continuum of care in people enrolling in care with advanced HIV disease in Latin America
  7. Prevalence and Factors Associated with Common Mental Disorders and Posttraumatic Stress Disorder Among Healthcare Workers in a Reference Center for Infectious Diseases During the COVID-19 Pandemic: A Survey-Based Cross-Sectional Study
  8. Atypical dengue fever in a partially vaccinated patient: a case report
  9. Sex, vaccination status, and comorbidities influence long COVID persistence
  10. Correction: Pooled Cohort Profile: ReCoDID Consortium’s Harmonized Acute Febrile Illness Arbovirus Meta-Cohort
  11. Correction: Pooled Cohort Profile: ReCoDID Consortium’s Harmonized Acute Febrile Illness Arbovirus Meta-Cohort (Preprint)
  12. Pooled Cohort Profile: ReCoDID Consortium’s Harmonized Acute Febrile Illness Arbovirus Meta-Cohort
  13. Exploring the Resurgence of a Neglected Disease: Lessons From the 2023–2024 Mpox Outbreak in Rio de Janeiro, Brazil
  14. Evidence of Zika Virus Reinfection by Genome Diversity and Antibody Response Analysis, Brazil
  15. Viral shedding of SARS-CoV-2 in body fluids associated with sexual activity: a systematic review and meta-analysis
  16. Cohort profile: follow-up of a household cohort throughout five epidemic waves of SARS-CoV-2 in Rio de Janeiro, Brazil
  17. Detection and persistence of Zika virus in body fluids and associated factors: a prospective cohort study
  18. Predictors of chronic joint pain after Chikungunya virus infection in the INOVACHIK prospective cohort study
  19. Pooled Cohort Profile: ReCoDID Consortium’s Harmonized Acute Febrile Illness Arbovirus Meta-Cohort (Preprint)
  20. Characteristics of women diagnosed with mpox infection compared to men: A case series from Brazil
  21. Cohort Profile: ReCoDID Consortium’s Harmonized Acute Febrile Illness Arbovirus Meta-Cohort
  22. A fatal respiratory complication of malaria caused by Plasmodium vivax
  23. Oral manifestations of COVID-19 in unvaccinated patients: a cross-sectional study
  24. Paracoccidioidomycosis and pregnancy: A 40-year single-center cohort study in the endemic area of Rio de Janeiro, Brazil
  25. SARS-CoV-2 Reinfection Cases in a Household-Based Prospective Cohort in Rio de Janeiro
  26. Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes
  27. The Role of Children in Household Transmission of SARS-CoV-2 Across Four Waves of the Pandemic
  28. Oral cavity manifestations in COVID-19 patients: A cross-sectional study
  29. Reduced ability to neutralize the Omicron variant among adults after infection and complete vaccination with BNT162b2, ChAdOx1, or CoronaVac and heterologous boosting
  30. Accuracy of saliva for SARS-CoV-2 detection in outpatients and their household contacts during the circulation of the Omicron variant of concern
  31. Challenges of acute febrile illness diagnosis in a national infectious diseases center in Rio de Janeiro: 16-year experience of syndromic surveillance
  32. Mortality rates by gender and sexual orientation reveal a disproportionally high mortality among cisgender men of unknown sexual orientation and men who have sex with women in a cohort of people living with HIV in Rio de Janeiro, Brazil
  33. Early diagnostic indicators of dengue versus other febrile illnesses in Asia and Latin America (IDAMS study): a multicentre, prospective, observational study
  34. Ambulatory and hospitalized patients with suspected and confirmed mpox: an observational cohort study from Brazil
  35. Long COVID-19 syndrome associated with Omicron XBB.1.5 infection: a case report
  36. Predictors of Chronic Joint Pain after Chikungunya Virus Infection in the INOVACHIK Prospective Cohort Study
  37. Cohort-profile: Household transmission of SARS-CoV-2 in a low-resource community in Rio de Janeiro, Brazil
  38. Chikungunya Virus Shedding in Semen: A Case Series
  39. Incidence of SARS-CoV-2 over four epidemic waves in a low-resource community in Rio de Janeiro, Brazil: A prospective cohort study
  40. Beyond arboviruses: A multicenter study to evaluate differential diagnosis of rash diseases and acute febrile illness cases in Rio de Janeiro, Brazil
  41. Myopericarditis associated with acute Zika virus infection: a case report
  42. Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving antiretroviral therapy
  43. Detection of Chikungunya virus in bodily fluids: The INOVACHIK cohort study
  44. Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil
  45. Fatal Brazilian spotted fever in a healthy military man during field training in Rio de Janeiro city, southeastern Brazil
  46. O que precisamos saber sobre a infecção humana pelo vírus monkeypox?
  47. What do we need to know about the monkeypox virus infection in humans?
  48. A prospective, multicentre, cohort study to assess the incidence of dengue illness in households from selected communities in Brazil (2014–2018)
  49. SARS-CoV-2 Infection Dynamics in Children and Household Contacts in a Slum in Rio de Janeiro
  50. Investigation of SARS-CoV-2 infection in dogs and cats of humans diagnosed with COVID-19 in Rio de Janeiro, Brazil
  51. Diagnostic performance of anti-Zika virus IgM, IgAM and IgG ELISAs during co-circulation of Zika, dengue, and chikungunya viruses in Brazil and Venezuela
  52. An initiative of cooperation in Zika virus research: the experience of the ZIKABRA study in Brazil
  53. Cohort profile: Study on Zika virus infection in Brazil (ZIKABRA study)
  54. Chikungunya associated vulvitis: case report and literature review
  55. Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention
  56. Co-Circulation of Two Independent Clades and Persistence of CHIKV-ECSA Genotype during Epidemic Waves in Rio de Janeiro, Southeast Brazil
  57. Accurate detection of Zika virus IgG using a novel immune complex binding ELISA
  58. The Zika Virus Individual Participant Data Consortium: A Global Initiative to Estimate the Effects of Exposure to Zika Virus during Pregnancy on Adverse Fetal, Infant, and Child Health Outcomes
  59. Bilateral median nerve neuritis after chikungunya virus infection
  60. Zika virus RNA excretion in sweat with concomitant detection in other body fluid specimens
  61. Zika virus infection as a cause of congenital brain abnormalities and Guillain-Barré syndrome: A living systematic review
  62. Congenital Zika syndrome: is the heart part of its spectrum?
  63. Circulation of chikungunya virus East/Central/South African lineage in Rio de Janeiro, Brazil
  64. Field diagnosis and genotyping of chikungunya virus using a dried reverse transcription loop-mediated isothermal amplification (LAMP) assay and MinION sequencing
  65. Zika Virus in Rectal Swab Samples
  66. Zika Virus Infection and Differential Diagnosis in a Cohort of HIV-Infected Patients
  67. Treatment of chikungunya musculoskeletal disorders: a systematic review
  68. Study on the persistence of Zika virus (ZIKV) in body fluids of patients with ZIKV infection in Brazil
  69. Behavioral, climatic, and environmental risk factors for Zika and Chikungunya virus infections in Rio de Janeiro, Brazil, 2015-16
  70. Accuracy of Zika virus disease case definition during simultaneous Dengue and Chikungunya epidemics
  71. Environmental and Climatic Risk Factors for Zika and Chikungunya Virus Infections in Rio de Janeiro, Brazil, 2015–2016
  72. The Emerging Zika Virus Threat: A Guide for Dermatologists
  73. Zika Virus Infection in Pregnant Women in Rio de Janeiro
  74. Zika virus infection
  75. Antiretroviral Therapy for the Prevention of HIV-1 Transmission
  76. Exanthema associated with Zika virus infection
  77. Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons
  78. Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study
  79. Zika Virus Infection in Pregnant Women in Rio de Janeiro—Preliminary Report
  80. Zika Virus Outbreak in Rio de Janeiro, Brazil: Clinical Characterization, Epidemiological and Virological Aspects
  81. Guillain-Barré syndrome associated with Zika virus infection
  82. First detection of autochthonous Zika virus transmission in a HIV-infected patient in Rio de Janeiro, Brazil
  83. Predictors of early menopause in HIV-infected women: a prospective cohort study
  84. Chikungunya: uma arbovirose em estabelecimento e expansão no Brasil
  85. Cascade of access to interventions to prevent HIV mother to child transmission in the metropolitan area of Rio de Janeiro, Brazil
  86. Suicide risk and alcohol and drug abuse in outpatients with HIV infection and Chagas disease
  87. Absence of Effect of Menopause Status at Initiation of First-Line Antiretroviral Therapy on Immunologic or Virologic Responses: A Cohort Study from Rio de Janeiro, Brazil
  88. Impact of a single safety-engineered device on the occurrence of percutaneous injuries in a general hospital in Brazil
  89. Factors associated with viral load suppression in HIV-infected pregnant women in Rio de Janeiro, Brazil
  90. Prevention of HIV-1 Infection with Early Antiretroviral Therapy
  91. Group B Streptococcus in a cohort of HIV-infected pregnant women: Prevalence of colonization, identification and antimicrobial susceptibility profile
  92. Adesão ao pré-natal de mulheres HIV+ que não fizeram profilaxia da transmissão vertical: um estudo sócio-comportamental e de acesso ao sistema de saúde
  93. Maternal Antiretroviral Use During Pregnancy and Infant Congenital Anomalies: The NISDI Perinatal Study
  94. Cohort Profile: NICHD International Site Development Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countries
  95. Antiretroviral Resistance among HIV Type 1-Infected Women First Exposed to Antiretrovirals during Pregnancy: Plasma versus PBMCs
  96. Trends in a Cohort of HIV-infected pregnant women in Rio de Janeiro, 1996-2004
  97. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth
  98. Nevirapine toxicity in a cohort of HIV-1–infected pregnant women
  99. Vertical transmission of HIV in Rio de Janeiro, Brazil
  100. Neutralization Titres and Vertical HIV-1 Transmission
  101. Accumulation of 3H-Phosphoinositides Mediated by Muscarinic Receptors in the Developing Chick Retina: Inhibition of Carbachol-Induced Response by Glutamate Receptors
  102. Vertical HIV-1 Transmission: Importance of Neutralizing Antibody Titer and Specificity
  103. Transient cyclic AMP accumulation mediated by dopamine D1 receptors in the chick embryo optic lobe